Biotin prices in Germany are anticipated to experience a slight increase by the end of April, supported by steady demand from downstream sectors and conservative pricing approaches by market players.
Market participants have reported that demand in major end-use industries such as pharmaceutical, nutraceutical and animal nutrition markets has been steady throughout the month. These sectors have shown resilient despite external economic headwinds, and their continued procurement activity has played a key role in stabilizing the market. With no substantial oversupply in the pipeline, several sellers have started revising their prices upward, albeit mildly, in line with ongoing off-take levels.
Suppliers also carefully navigate prices to maintain profitability. The price strategy has moved towards the preservation of the margin rather than aggressive competition, with most sellers looking for a balance between turnover and profitability. As a result, Biotin prices...
